[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gybels et al., 1988 - Google Patents

Intrathecal programmed infusion of Baclofen in spasticity

Gybels et al., 1988

Document ID
14437649061123181147
Author
Gybels J
De Sutter P
Weinmann P
Publication year
Publication venue
Clinical Neurology and Neurosurgery

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Rudge et al. Encephalomyelitis in primary hypogammaglobulinaemia
Lance et al. A physiological approach to clinical neurology
Johnson et al. Central nervous system manifestations of chickenpox
TWI233806B (en) Pharmaceutical composition for treating diabetes by local administration
DE69837324T2 (en) TREATMENT OF MULTIPLE SCLEROSIS BY USING COPOLYMER-1
Dubin et al. Acute hemorrhagic edema of childhood: an unusual variant of leukocytoclastic vasculitis
CN108271354A (en) Composition comprising bacterium bacterial strain
CN102458476B (en) Compositions and methods for treatment of multiple sclerosis
Albanese et al. Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients.
Christ et al. The application of gene therapy to the treatment of erectile dysfunction
ZIEGLER Acute disseminated encephalitis: Some therapeutic and diagnostic considerations
Whiteside A controlled study of benzydamine oral rinse (‘Difflam’) in general practice
Thrush et al. How benign a symptom is facial numbness?
Bhat et al. Intravenous daclizumab for recalcitrant ocular inflammatory disease
Solomon et al. The use of sodoku in the treatment of general paralysis: a preliminary report
Gybels et al. Intrathecal programmed infusion of Baclofen in spasticity
Duncan et al. Methylprednisolone therapy in tropical spastic paraparesis.
Lask Treatment of Vomiting of Pregnancy with Antihistamines
Goin et al. Pauci-symptomatic foodborne botulism due to Clostridium botulinum type B with predominant ophthalmologic presentation possibly after consumption of honey
Fellman Facial diplegia following ethylene glycol ingestion
Arteaga-Pérez et al. Multiple dose toxicity study of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 intravenously administered to Cercopithecus aethiops sabaeus monkeys
Gadoth et al. Permanent tetraplegia as a consequence of tetanus neonatorum: Evidence for widespread lower motor neuron damage
AU611961B2 (en) Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis
CN106539815A (en) Application of the ring dinucleotide in preventing and treating multiple sclerosis
Maddison Neuromyotonia